Pre-Seed, Seed, Series A
$1.0M – $20.0M
$12.0B
12+ companies
12 partners
Investment Thesis
ARCH is committed to building enduring companies that leverage advancements in technology and biology, with deep expertise in cell therapy and biotechnology.
Meet the Team
Industry Focus
Invests In
Portfolio Companies (12)
Other
Beam Therapeutics
Lyell Immunopharma
Halo Top
Calm
Codiak BioSciences, Inc. (CIK 0001659352)
"Discovered via sec_edgar_form_d (high confidence)"
SEC Form D filing mentioning ARCH Venture Partners
ARCH Venture Fund VIII Overage, L.P. (CIK 0001617237)
"Discovered via sec_edgar_form_d (high confidence)"
SEC Form D filing mentioning ARCH Venture Partners
ARCH Venture Fund IX Overage, L.P. (CIK 0001666307)
"Discovered via sec_edgar_form_d (high confidence)"
SEC Form D filing mentioning ARCH Venture Partners
ARCH Venture Fund XII, L.P. (CIK 0001906837)
"Discovered via sec_edgar_form_d (high confidence)"
SEC Form D filing mentioning ARCH Venture Partners
ARCH Venture Fund IX, L.P. (CIK 0001666306)
"Discovered via sec_edgar_form_d (high confidence)"
SEC Form D filing mentioning ARCH Venture Partners
ARCH Venture Fund XI, L.P. (CIK 0001831802)
"Discovered via sec_edgar_form_d (high confidence)"
SEC Form D filing mentioning ARCH Venture Partners
Browse More Investors
Frequently Asked Questions
See if ARCH Venture Partners is a match for your startup
Upload your pitch deck to see how well you match with ARCH Venture Partners and 200+ other VC firms.